冬虫夏草及相关产品治疗肾纤维化的潜在策略
肾纤维化目前尚无有效药物,冬虫夏草具有免疫调节、抗肿瘤、抗炎和抗氧化等药理作用,可能预防肾、肝和心脏疾病,也有报道对肾纤维化有效。本文综述冬虫夏草抗肾纤维化的潜在机制,聚焦炎症、氧化应激、凋亡、自噬调节、减少细胞外基质沉积和成纤维细胞活化,并讨论已发表的临床试验和荟萃分析。现有临床研究支持冬虫夏草及相关产品作为常规药物辅助剂对慢性肾脏病患者有益,但研究质量低且异质性显著,需高质量、大样本随机对照试验评估疗效和安全性。
要点
- 冬虫夏草可能通过抗炎、抗氧化、调节自噬和减少细胞外基质沉积等机制抗肾纤维化。
- 现有临床研究支持冬虫夏草及相关产品作为慢性肾脏病常规治疗的辅助剂。
- 现有临床研究质量低且异质性显著,需高质量大样本随机对照试验验证。
核心结论
- 冬虫夏草及相关产品可能是治疗肾纤维化的潜在策略。
- 现有临床研究支持冬虫夏草及相关产品作为常规药物辅助剂对慢性肾脏病患者有益。
研究设计与样本
- 本文为综述,回顾冬虫夏草抗肾纤维化的潜在机制,并讨论相关已发表的临床试验和荟萃分析。
主要发现
- 冬虫夏草可能通过影响炎症、氧化应激、凋亡、自噬调节、减少细胞外基质沉积和成纤维细胞活化等机制对抗肾纤维化。
临床怎么用
- 冬虫夏草及相关产品可考虑作为慢性肾脏病患者的常规药物辅助治疗。
局限性
- 现有临床研究质量低且异质性显著。
- 需要方法学质量好、实验设计合理、大样本的随机对照试验评估冬虫夏草的疗效和安全性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
At present, there is no effective drug for the treatment of renal fibrosis; in particular, a safe and effective treatment for renal fibrosis should be established. Cordyceps has several medical effects, including immunoregulatory, antitumor, anti-inflammatory, and antioxidant effects, and may prevent kidney, liver, and heart diseases. Cordyceps has also been reported to be effective in the treatment of renal fibrosis. In this paper, we review the potential mechanisms of Cordyceps against renal fibrosis, focusing on the effects of Cordyceps on inflammation, oxidative stress, apoptosis, regulation of autophagy, reduction of extracellular matrix deposition, and fibroblast activation. We also discuss relevant published clinical trials and meta-analyses. Available clinical studies support the possibility that Cordyceps and related products provide benefits to patients with chronic kidney diseases as adjuvants to conventional drugs. However, the existing clinical studies are limited by low quality and significant heterogeneity. The use of Cordyceps and related products may be a potential strategy for the treatment of renal fibrosis. Randomized controlled trial studies with good methodological quality, favorable experimental design, and large sample size are needed to evaluate the efficacy and safety of Cordyceps.
引用
- Tan W, Wang Y, Dai H, et al. Potential Therapeutic Strategies for Renal Fibrosis: Cordyceps and Related Products. Front Pharmacol. 2022. PMID: 35873549. doi:10.3389/fphar.2022.932172
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。